Skip to content
Primary Menu
Clinical
Medications for Opioid Use Disorder (MOUD)
Pain or Opioid Withdrawal in Hospitalized Patients
Low dose/Microdose Buprenorphine Instructions
Buprenorphine Induction Pathway
Perinatal Resources for Opioid Use Disorder (PROUD)
All About Xylazine
Substance Use Navigator Team
Success Stories
Education
Working as a Peer in Recovery
How to Mitigate Stigma
All About the X Waiver
Addiction Medicine Interest Group
Research
Clinical Trials
Research in the News
Publications
Harm Reduction
All About Fentanyl
All About Xylazine
How to Use Narcan
Harm Reduction Interest Group
Trainings & Events
Trainings
Upcoming Events
Events Archive
News & Policy
Policy
About Us
Donate
Leadership
CAMP Team
Advisory Board
Newsletters
Get Help
An analysis of cannabinoid hyperemesis syndrome Reddit posts and themes
Post navigation
Previous:
Barriers to opioid use disorder treatment: A comparison of self-reported information from social media with barriers found in literature
Next:
Incidence of Precipitated Withdrawal During a Multisite Emergency Department-Initiated Buprenorphine Clinical Trial in the Era of Fentanyl
Clinical
Medications for Opioid Use Disorder (MOUD)
Pain or Opioid Withdrawal in Hospitalized Patients
Low dose/Microdose Buprenorphine Instructions
Buprenorphine Induction Pathway
Perinatal Resources for Opioid Use Disorder (PROUD)
All About Xylazine
Substance Use Navigator Team
Success Stories
Education
Working as a Peer in Recovery
How to Mitigate Stigma
All About the X Waiver
Addiction Medicine Interest Group
Research
Clinical Trials
Research in the News
Publications
Harm Reduction
All About Fentanyl
All About Xylazine
How to Use Narcan
Harm Reduction Interest Group
Trainings & Events
Trainings
Upcoming Events
Events Archive
News & Policy
Policy
About Us
Donate
Leadership
CAMP Team
Advisory Board
Newsletters
Get Help
